Dana-Farber Cancer Institute

The following description was provided by the Dana-Farber Cancer Institute:

Ever since Sidney Farber, MD, pioneered chemical therapies to treat children with leukemia in 1947, Dana-Farber has forged a groundbreaking path: 70+ years of research discovery and innovation have revolutionized cancer diagnosis and treatment, for the benefit of all their patients, adult and pediatric. Dana-Farber's equal emphasis on patient care and research means that their leading-edge research is informed by patient care – and their patient care relies on leading-edge research.

Browse available plasmids from each Dana-Farber PI listed below.

Resources

• More information on Dana-Farber Cancer Institute
• Addgene Blog Posts or Newsletter Articles featuring technologies from the Dana-Farber:
  • dTAG - You're it!
  • Interview with Dr. William Hahn

Dana-Farber Cancer Institute Sharing Statistics

49 Depositing Scientists

Sharing 2,512 Reagents

Requested 61,844 Times

Shipped to 75 Countries

Depositing Principal Investigators (PIs)

PI Name
Bruce Spiegelman
Pamela Silver
Stanley Korsmeyer
Lynda Chin
Yoshihiro Nakatani
William Sellers
William Hahn
Thomas Roberts
Matthew Meyerson
Ramesh Shivdasani
Jean Zhao
Carl Novina
Pere Puigserver
William Kaelin
Ronny Drapkin
Marc Vidal
Peter Sicinski
Rosalind Segal
Stuart Calderwood
David Weinstock
James Iglehart
Wayne Marasco
Kornelia Polyak
James Bradner
Thomas Look
Nathanael Gray
Xiaole Shirley Liu
Stephanie Dougan
Kai Wucherpfennig
Catherine Wu
Eric Fischer
David Livingston
James A. DeCaprio
Andrew Aguirre
Chris Sander
Kimberly Stegmaier
Brendan Price
Rizwan Haq
Benjamin Ebert
Andrew Kung
Alon Herschhorn
Joseph Sodroski
Charles Stiles
Nicholas Gauthier
Derin Keskin
Matthew Oser
Philip Kranzusch
Coleman Lindsley
David Pellman